Who owns Seer, Inc. (SEER)? Elite investor 13F holders
2 tracked elite investors reported holding Seer, Inc as of 2026-06-30, including Renaissance Technologies LLC, Voss Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | SEER INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1635930.00 USD | 985500.000000 | Shares | add | Original filing |
| Voss Capital | SEER INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 227903.00 USD | 137291.000000 | Shares | buy | Original filing |
| D.E. Shaw | SEER INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.